关注
Ishen Seocharan
Ishen Seocharan
South African Medical Research Council
在 mrc.ac.za 的电子邮件经过验证
标题
引用次数
引用次数
年份
Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland
BL Sharp, I Kleinschmidt, E Streat, R Maharaj, KI Barnes, DN Durrheim, ...
The American journal of tropical medicine and hygiene 76 (1), 42, 2007
3252007
High rate of asymptomatic carriage associated with variant strain omicron
N Garrett, A Tapley, J Andriesen, I Seocharan, LH Fisher, L Bunts, N Espy, ...
MedRxiv, 2022
1312022
Effectiveness of Ad26. COV2. S and BNT162b2 vaccines against Omicron variant in South Africa
G Gray, S Collie, A Goga, N Garrett, J Champion, I Seocharan, L Bamford, ...
New England Journal of Medicine 386 (23), 2243-2245, 2022
1072022
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey
S Moyo, F Ismail, M Van der Walt, N Ismail, N Mkhondo, S Dlamini, ...
The Lancet Infectious Diseases 22 (8), 1172-1180, 2022
982022
Epidemiology of malaria in South Africa: from control to elimination
R Maharaj, J Raman, N Morris, D Moonasar, DN Durrheim, I Seocharan, ...
South African Medical Journal 103 (10), 779-783, 2013
952013
Factors influencing the effectiveness of malaria control in Bioko Island, equatorial Guinea
I Kleinschmidt, M Torrez, C Schwabe, L Benavente, I Seocharan, ...
The American journal of tropical medicine and hygiene 76 (6), 1027, 2007
922007
Developing an evidence-based decision support system for rational insecticide choice in the control of African malaria vectors
M Coleman, B Sharp, I Seocharan, J Hemingway
Journal of medical entomology 43 (4), 663-668, 2006
872006
Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study
LG Bekker, N Garrett, A Goga, L Fairall, T Reddy, N Yende-Zuma, ...
The Lancet 399 (10330), 1141-1153, 2022
802022
The feasibility of malaria elimination in South Africa
R Maharaj, N Morris, I Seocharan, P Kruger, D Moonasar, A Mabuza, ...
Malaria Journal 11, 1-10, 2012
802012
High asymptomatic carriage with the omicron variant in South Africa
N Garrett, A Tapley, J Andriesen, I Seocharan, LH Fisher, L Bunts, N Espy, ...
Clinical Infectious Diseases 75 (1), e289-e292, 2022
752022
COVID deaths in South Africa: 99 days since South Africa's first death
V Pillay-van Wyk, D Bradshaw, P Groenewald, I Seocharan, S Manda, ...
SAMJ: South African Medical Journal 110 (10), 0-0, 2020
522020
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26. COV2 during an Omicron COVID19 wave …
GE Gray, S Collie, N Garrett, A Goga, J Champion, M Zylstra, T Reddy, ...
MedRxiv, 2021.12. 28.21268436, 2021
512021
Symptom cluster is associated with prolonged return-to-play in symptomatic athletes with acute respiratory illness (including COVID-19): a cross-sectional study—AWARE study I
M Schwellnus, N Sewry, C Snyders, K Kaulback, PS Wood, I Seocharan, ...
British journal of sports medicine 55 (20), 1144-1152, 2021
382021
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
A Goga, LG Bekker, N Garrett, T Reddy, N Yende-Zuma, L Fairall, ...
The Lancet 400 (10348), 269-271, 2022
372022
Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26. COV2. S vaccine trial …
A Goga, LG Bekker, N Garrett, T Reddy, N Yende-Zuma, L Fairall, ...
MedRxiv, 2021.12. 21.21268171, 2021
332021
Decadal epidemiology of malaria in KwaZulu-Natal, a province in South Africa targeting elimination
R Maharaj, I Seocharan, B Qwabe, M Mkhabela, S Kissoon, V Lakan
Malaria journal 18, 1-7, 2019
332019
Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority …
D Bath, J Cook, J Govere, P Mathebula, N Morris, K Hlongwana, J Raman, ...
The Lancet 397 (10276), 816-827, 2021
262021
Safety evaluation of the single-dose Ad26. COV2. S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
S Takuva, A Takalani, I Seocharan, N Yende-Zuma, T Reddy, ...
PLoS Medicine 19 (6), e1004024, 2022
222022
Medical encounters in a 90-km ultramarathon running event: a 6-year study in 103 131 race starters—SAFER XVII
N Sewry, M Schwellnus, J Boulter, I Seocharan, E Jordaan
Clinical Journal of Sport Medicine 32 (1), e61-e67, 2022
132022
Symptom number and reduced preinfection training predict prolonged return to training after SARS-CoV-2 in athletes: AWARE IV
C Snyders, M Schwellnus, N Sewry, K Kaulback, P Wood, I Seocharan, ...
Medicine and Science in Sports and Exercise 55 (1), 1, 2022
102022
系统目前无法执行此操作,请稍后再试。
文章 1–20